美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Therapeutics

33.73

-0.8400-2.43%

盤後：33.730.00000.00%17:06 EDT

成交量：28.80萬

成交額：992.61萬

市值：9.49億

市盈率：-19.06

高：35.49

開：35.35

低：33.65

收：34.57

資料載入中...

總覽公司新聞公告

Lisata Therapeutics, Inc.盤中異動急速下挫7.63%

Intensity Therapeutics, Inc.盤中異動股價大漲5.05%

Apogee Therapeutics新藥APG777在特應性皮炎試驗中取得積極結果

老虎资讯综合

Sarepta Therapeutics, Inc.7月3日成交額為4532.62萬美元

Galectin Therapeutics Inc.7月3日成交額為52.13萬美元

Cero Therapeutics Holdings, Inc.7月3日成交額為53.02萬美元

據報Summit與阿斯利康洽談高達150億美元合作

C4 Therapeutics, Inc.盤中異動股價大跌5.26%報1.44美元

SUMMIT THERAPEUTICS跌幅擴大一度下跌8.4%。

Mersana Therapeutics, Inc.盤中異動快速上漲5.29%

Zevra Therapeutics, Inc.盤中異動股價大漲5.10%報9.89美元

Tango Therapeutics, Inc.盤中異動股價大漲5.31%

Alaunos Therapeutics, Inc.盤中異動早盤急速跳水6.13%

Xortx Therapeutics Inc.股價重挫15.70% 市值跌50.13萬美元

阿什瓦塔治療公司分享了SubQ MGB在DME、AMD中的積極中期2期結果Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD

Windtree Therapeutics, Inc.7月2日成交額為6091.30萬美元

Vyne Therapeutics Inc.7月2日成交額為416.95萬美元

Sage Therapeutics, Inc.7月2日成交額為1350.52萬美元

Neumora Therapeutics, Inc.7月2日成交額為91.08萬美元

Kazia Therapeutics Limited7月2日成交額為7.59萬美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LENZ/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.73,"timestamp":1752868800000,"preClose":34.57,"halted":0,"volume":288046,"hourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"delay":0,"floatShares":12538526,"shares":28146154,"eps":-1.769251,"marketStatus":"休市中","change":-0.84,"latestTime":"07-18 16:00:00 EDT","open":35.35,"high":35.485,"low":33.645,"amount":9926090.220002001,"amplitude":0.053225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":34.57,"preHourTrading":{"tag":"盘前","latestPrice":35.3,"preClose":34.57,"latestTime":"09:29 EDT","volume":499,"amount":17604.058825,"timestamp":1752845399999},"postHourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"volumeRatio":0.8035328724389679,"impliedVol":1.0249,"impliedVolPercentile":0.8986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12538526,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.8035328724389679,"shares":28146154,"dividePrice":0,"high":35.485,"amplitude":0.053225,"preClose":34.57,"low":33.645,"week52Low":16.535,"pbRate":"4.94","week52High":38.93,"institutionHeld":0,"latestPrice":33.73,"eps":-1.769251,"divideRate":0,"volume":288046,"delay":0,"ttmEps":-1.769251,"open":35.35,"prevYearClose":28.87,"prevWeekClose":34.69,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":34.69,"twentyDayClose":30.03,"sixtyDayClose":25.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549355868","title":"Lisata Therapeutics, Inc.盤中異動 急速下挫7.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549355868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549355868?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 21:31","pubTimestamp":1751895108,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分，Lisata Therapeutics, Inc.股票出现波动，股价快速跳水7.63%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1370.96%、744.87%、657.19%，振幅较大的相关个股有Nucana Plc、Mustang Bio, Inc.、Exicure, Inc.，振幅分别为11.94%、10.04%、9.29%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗实体瘤和其他疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721314995399ce3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070721314995399ce3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2549530606","title":"Intensity Therapeutics, Inc.盤中異動 股價大漲5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549530606?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 21:31","pubTimestamp":1751895065,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分，Intensity Therapeutics, Inc.股票出现异动，股价急速上涨5.05%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1365.51%、744.45%、655.43%，振幅较大的相关个股有Nucana Plc、Azitra Inc、Annovis Bio, Inc.，振幅分别为9.70%、4.27%、4.24%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司，开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213106a43bf5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213106a43bf5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INTS","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"1111089659","title":"Apogee Therapeutics新藥APG777在特應性皮炎試驗中取得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1111089659","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111089659?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 19:07","pubTimestamp":1751886470,"startTime":"0","endTime":"0","summary":"$Apogee Therapeutics$是一家临床阶段的$生物$技术公司，致力于推进优化的新型生物制品，具有在最大的炎症和免疫（I&I）市场中差异化疗效和给药的潜力，今天宣布了APG777的第II期APEX临床试验A部分的16周积极数据。今天的结果使我们更接近这一愿景，我们认为进一步降低了APG777获得批准的风险。\"II期APEX临床试验是一项随机、安慰剂对照研究，评估APG777在中度至重度AD患者中的效果。受益于治疗的患者继续进行维持给药，评估3个月或6个月的APG777给药方案。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apogee Therapeutics新药APG777在特应性皮炎试验中取得积极结果","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4139","APGE"],"gpt_icon":0},{"id":"2548354385","title":"Sarepta Therapeutics, Inc.7月3日成交額為4532.62萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548354385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548354385?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 14:05","pubTimestamp":1751609132,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Sarepta Therapeutics, Inc.成交额为4532.62万美元，成交额较昨日减少45.97%，当日成交量为248.44万股。Sarepta Therapeutics, Inc.于2025年7月3日涨0.25%，报18.24美元，该股过去5个交易日涨5.86%，年初至今跌85.0%，过去60日跌65.19%。Sarepta的战略包括专有的RNA靶向技术平台，用于开发新型药物产品，以治疗广泛的疾病并解决关键的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704140542a4cec9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704140542a4cec9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00B2B36J28.USD","LENZ","IE0009355771.USD","IE00BJT1NW94.SGD","BK4539","BK4585","SRPT","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139"],"gpt_icon":0},{"id":"2548337271","title":"Galectin Therapeutics Inc.7月3日成交額為52.13萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548337271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548337271?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 10:10","pubTimestamp":1751595046,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Galectin Therapeutics Inc.成交额为52.13万美元，成交额较昨日减少11.50%，当日成交量为23.95万股。Galectin Therapeutics Inc.于2025年7月3日涨0.46%，报2.18美元，该股过去5个交易日跌7.23%，年初至今涨68.99%，过去60日涨63.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|52.13万|-11.50%|23.95万|#|2025-07-02|58.90万|-39.74%|27.20万|#|2025-07-01|97.74万|-5.38%|44.70万|#|2025-06-30|103.30万|-77.52%|45.71万|#|2025-06-27|459.49万|279.56%|194.67万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GALT","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2548061334","title":"Cero Therapeutics Holdings, Inc.7月3日成交額為53.02萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548061334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548061334?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 09:29","pubTimestamp":1751592578,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌34.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|53.02万|-38.27%|5.68万|#|2025-07-02|85.88万|22.72%|9.09万|#|2025-07-01|69.98万|-47.04%|7.50万|#|2025-06-30|132.14万|-46.12%|13.55万|#|2025-06-27|245.26万|-13.78%|24.72万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","CERO"],"gpt_icon":0},{"id":"2548331612","title":"據報Summit與阿斯利康洽談高達150億美元合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2548331612","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548331612?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 09:15","pubTimestamp":1751591743,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4568","BK4539","BK4585","LU0109394709.USD","LENZ","BK4139","BK4588","LU0889565916.HKD","LU1829250122.USD","BK4007","AZN","LU2236285917.USD","LU2417539215.USD","LU2462157665.USD","LU0320765992.SGD","LU2456880835.USD"],"gpt_icon":0},{"id":"2548389313","title":"C4 Therapeutics, Inc.盤中異動 股價大跌5.26%報1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548389313","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548389313?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 00:09","pubTimestamp":1751558959,"startTime":"0","endTime":"0","summary":"北京时间2025年07月04日00时09分，C4 Therapeutics, Inc.股票出现波动，股价快速跳水5.26%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家临床阶段的生物制药公司，致力于实现靶向蛋白质降解科学的承诺，创造新一代药物，改变患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040009199798cdd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040009199798cdd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CCCC","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2548829383","title":"SUMMIT THERAPEUTICS跌幅擴大一度下跌8.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548829383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548829383?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 22:35","pubTimestamp":1751553319,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2548388751","title":"Mersana Therapeutics, Inc.盤中異動 快速上漲5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548388751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548388751?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 22:28","pubTimestamp":1751552939,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时28分，Mersana Therapeutics, Inc.股票出现波动，股价大幅上涨5.29%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，专注于开发抗体-药物偶联物 ，为需求未得到满足的癌症患者提供具有临床意义的益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032228599798b84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032228599798b84e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRSN","BK4139","BK4007","LENZ","BK4539","BK4563"],"gpt_icon":0},{"id":"2548638863","title":"Zevra Therapeutics, Inc.盤中異動 股價大漲5.10%報9.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548638863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548638863?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 22:10","pubTimestamp":1751551817,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时10分，Zevra Therapeutics, Inc.股票出现波动，股价急速拉升5.10%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家专注于罕见病的公司，将科学、数据和患者需求相结合，为那些治疗选择有限或根本没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703221017a72cea9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703221017a72cea9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ZVRA","BK4007","BK4539"],"gpt_icon":0},{"id":"2548388528","title":"Tango Therapeutics, Inc.盤中異動 股價大漲5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548388528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548388528?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 22:05","pubTimestamp":1751551501,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时05分，Tango Therapeutics, Inc.股票出现波动，股价快速拉升5.31%。截至发稿，该股报5.95美元/股，成交量10.1883万股，换手率0.09%，振幅4.21%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Theratechnologies Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Oragenics Inc.较为活跃，换手率分别为1871.45%、674.23%、179.61%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Clearmind Medicine Inc.，振幅分别为63.64%、49.41%、33.22%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703220501a4cd8a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703220501a4cd8a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","LENZ","TNGX"],"gpt_icon":0},{"id":"2548800697","title":"Alaunos Therapeutics, Inc.盤中異動 早盤急速跳水6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548800697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548800697?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 21:46","pubTimestamp":1751550365,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时46分，Alaunos Therapeutics, Inc.股票出现异动，股价快速下跌6.13%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Theratechnologies Inc.涨幅较大，Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1774.63%、898.69%、631.46%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为54.55%、38.11%、36.41%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc是一家临床阶段的细胞免疫肿瘤学公司，致力于通过采用TCR-T细胞疗法治疗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214605a4cd82b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214605a4cd82b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","TCRT","BK4539","BK4139"],"gpt_icon":0},{"id":"2548807465","title":"Xortx Therapeutics Inc.股價重挫15.70% 市值跌50.13萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548807465?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 21:31","pubTimestamp":1751549488,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分，Xortx Therapeutics Inc.股票出现异动，股价急速下挫15.70%。截至发稿，该股报0.843美元/股，成交量316.985万股，换手率83.68%，振幅0.20%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1677.81%、514.10%、437.39%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.，振幅分别为27.18%、26.73%、12.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","LENZ","XRTX"],"gpt_icon":0},{"id":"2548875812","title":"阿什瓦塔治療公司分享了SubQ MGB在DME、AMD中的積極中期2期結果Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2548875812","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548875812?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 15:36","pubTimestamp":1751528160,"startTime":"0","endTime":"0","summary":"Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果July 03, 20252025年7月3日Ashvattha Therapeutics has announced promising interim results from its ongoing phase 2 study of subcutaneous  migaldendranib  for the treatment of diabetic macular edema  and wet age-related macular degeneration . The findings were presented at the MaculArt Meeting, held from June 29 to July 1, 2025, in Paris.Ashvattha Therapeutics 宣布了其正在进行的皮下注射米加仑丹尼治疗糖尿病性黄斑水肿和湿性年龄相关性黄斑变性的 2 期研究的积极中期结果。这些研究成果于 2025 年 6 月 29 日至 7 月 1 日在巴黎举行的 MaculArt 会议上公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031540199534f13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031540199534f13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4554","IE0004445239.USD","LU0127658192.USD","LU1988902786.USD","LU1880398471.USD","LU2458330169.SGD","AMD","IE00B5949003.HKD","LU1242518931.SGD","LU1316542783.SGD","LU0056508442.USD","BK4543","LU0823421416.USD","BK4605","LU0979878070.USD","LU1303367103.USD","BK4573","LU1803068979.SGD","GFS","BK4534","BK4612","LU1242518857.USD","LU2458330243.SGD","BK4529","BK4575","BK4614","LU0390134368.USD","LU0719512351.SGD","LU0823421333.USD","LU1880398554.USD","LU0823434740.USD","LU2360106780.USD","IE00BMPRXR70.SGD","LU1951198990.SGD","LU0082616367.USD","LU2264538146.SGD","BK4585","LU1923623000.USD","LU1989764664.SGD","BK4532","LU1852331112.SGD","IE00BMPRXN33.USD","BK4539","LU1064131342.USD","BK4007","BK4588","BK4139","LU0198837287.USD","LENZ","LU2250418816.HKD"],"gpt_icon":1},{"id":"2548935879","title":"Windtree Therapeutics, Inc.7月2日成交額為6091.30萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548935879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548935879?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 15:35","pubTimestamp":1751528155,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Windtree Therapeutics, Inc.成交额为6091.30万美元，成交额较昨日增加7308.03%，当日成交量为7867.76万股。Windtree Therapeutics, Inc.于2025年7月2日涨40.0%，报0.77美元，该股过去5个交易日涨108.11%，年初至今跌95.59%，过去60日跌40.77%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|6091.30万|7308.03%|7867.76万|#|2025-07-01|82.23万|-33.45%|159.56万|#|2025-06-30|123.56万|113.55%|255.13万|#|2025-06-27|57.86万|-81.37%|132.36万|#|2025-06-26|310.65万|612.39%|701.43万|Windtree Therapeutics Inc 是一家生物技术公司，专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703161153a4ccda98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703161153a4ccda98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WINTW","BK4139","BK4539","BK4007","WINT","LENZ"],"gpt_icon":0},{"id":"2548876533","title":"Vyne Therapeutics Inc.7月2日成交額為416.95萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548876533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548876533?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 15:23","pubTimestamp":1751527437,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Vyne Therapeutics Inc.成交额为416.95万美元，成交额较昨日增加21.28%，当日成交量为263.88万股。Vyne Therapeutics Inc.于2025年7月2日跌14.69%，报1.51美元，该股过去5个交易日涨10.22%，年初至今跌54.93%，过去60日跌3.21%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|416.95万|21.28%|263.88万|#|2025-07-01|343.79万|103.27%|188.80万|#|2025-06-30|169.13万|-10.91%|106.36万|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2548824468","title":"Sage Therapeutics, Inc.7月2日成交額為1350.52萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548824468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548824468?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 13:39","pubTimestamp":1751521197,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Sage Therapeutics, Inc.成交额为1350.52万美元，成交额较昨日增加73.01%，当日成交量为148.28万股。Sage Therapeutics, Inc.于2025年7月2日涨0.0%，报9.08美元，该股过去5个交易日跌1.84%，年初至今涨67.22%，过去60日涨32.36%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|1350.52万|73.01%|148.28万|#|2025-07-01|780.60万|-68.53%|85.87万|#|2025-06-30|2480.35万|-42.16%|272.33万|#|2025-06-27|4288.02万|399.47%|467.55万|#|2025-06-26|858.52万|-11.48%|93.00万|Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。该公司还有其他药物正在研发中，例如 SAGE-324、Dalzanemdor  等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134008a72bf8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134008a72bf8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","LENZ","SAGE"],"gpt_icon":0},{"id":"2548829651","title":"Neumora Therapeutics, Inc.7月2日成交額為91.08萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548829651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548829651?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 12:20","pubTimestamp":1751516425,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Neumora Therapeutics, Inc.成交额为91.08万美元，成交额较昨日增加20.11%，当日成交量为113.66万股。Neumora Therapeutics, Inc.于2025年7月2日跌1.77%，报0.782美元，该股过去5个交易日跌3.19%，年初至今跌92.62%，过去60日涨6.13%。该公司已扩大其治疗产品线，目前包括七个临床和临床前神经科学项目，旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","NMRA","BK4139","BK4539"],"gpt_icon":0},{"id":"2548825301","title":"Kazia Therapeutics Limited7月2日成交額為7.59萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548825301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548825301?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 11:12","pubTimestamp":1751512326,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Kazia Therapeutics Limited成交额为7.59万美元，成交额较昨日减少62.12%，当日成交量为1.17万股。Kazia Therapeutics Limited于2025年7月2日跌0.75%，报6.58美元，该股过去5个交易日跌0.15%，年初至今跌25.65%，过去60日涨85.09%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","KZIA","BK4139","BK4539","NVGNF"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-18","current":-20.381494,"percent":0.009677,"low":-20.747029,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"high":-5.069183,"avg":-11.412713,"sd":4.103005,"marketCap":973012543},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543}],"updateTime":1752970572734}}}